Circadian properties of cancer stem cells in glioma cell cultures and tumorspheres

Cancer Letters

Volumn 345, Issue 1, 2014, Pages 65-74

  Sharma, Vishal Premdev ^a   Anderson, Nathan Thomas ^a   Geusz, Michael Eric ^a  

^a BOWLING GREEN STATE UNIVERSITY   (United States)

Author keywords

C6; Cancer stem cell; Circadian rhythms; Glioma; Tumorsphere

Indexed keywords

C6; CANCER STEM CELL; CIRCADIAN RHYTHMS; GLIOMA; TUMORSPHERE;

ANIMALS; CIRCADIAN RHYTHM; GENE EXPRESSION; GLIOMA; MICROSCOPY, CONFOCAL; NEOPLASTIC STEM CELLS; RATS; SPHEROIDS, CELLULAR; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 84893748189     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.11.009     Document Type: Article

References (80)

1. Fujioka A., Takashima N., Shigeyoshi Y. Circadian rhythm generation in a glioma cell line. Biochem. Biophys. Res. Commun. 2006, 346:169-174.
2. Prolo L.M., Takahashi J.S., Herzog E.D. Circadian rhythm generation and entrainment in astrocytes. J. Neurosci. 2005, 25:404-408.
3. Reppert S.M., Weaver D.R. Coordination of circadian timing in mammals. Nature 2002, 418:935-941.
4. Stevens R.G. Circadian disruption and breast cancer: from melatonin to clock genes. Epidemiology 2005, 16:254-258.
5. Levi F., Schibler U. Circadian rhythms: mechanisms and therapeutic implications. Annu. Rev. Pharmacol. Toxicol. 2007, 47:593-628.
6. Filipski E., Innominato P.F., Wu M., Li X.M., Iacobelli S., Xian L.J., Levi F. Effects of light and food schedules on liver and tumor molecular clocks in mice. J. Natl. Cancer Inst. 2005, 97:507-517.
7. Lee S., Donehower L.A., Herron A.J., Moore D.D., Fu L. Disrupting circadian homeostasis of sympathetic signaling promotes tumor development in mice. PLoS One 2010, 5:e10995.
8. Oshima T., Takenoshita S., Akaike M., Kunisaki C., Fujii S., Nozaki A., Numata K., Shiozawa M., Rino Y., Tanaka K., Masuda M., Imada T. Expression of circadian genes correlates with liver metastasis and outcomes in colorectal cancer. Oncol. Rep. 2011, 25:1439-1446.
9. Lowrey P.L., Takahashi J.S. Genetics of circadian rhythms in Mammalian model organisms. Adv. Genet. 2011, 74:175-230.
10. Tamanini F., Yagita K., Okamura H., van der Horst G.T. Nucleocytoplasmic shuttling of clock proteins. Methods Enzymol. 2005, 393:418-435.
11. DiTacchio L., Le H.D., Vollmers C., Hatori M., Witcher M., Secombe J., Panda S. Histone lysine demethylase JARID1a activates CLOCK-BMAL1 and influences the circadian clock. Science 2011, 333:1881-1885.
12. Lee C.C. Tumor suppression by the mammalian period genes. Cancer Causes Control: CCC 2006, 17:525-530.
13. Elshazley M., Sato M., Hase T., Yamashita R., Yoshida K., Toyokuni S., Ishiguro F., Osada H., Sekido Y., Yokoi K., Usami N., Shames D.S., Kondo M., Gazdar A.F., Minna J.D., Hasegawa Y. The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma. Int. J. Cancer 2012, 131:2820-2831.
14. Oda A., Katayose Y., Yabuuchi S., Yamamoto K., Mizuma M., Shirasou S., Onogawa T., Ohtsuka H., Yoshida H., Hayashi H., Rikiyama T., Kim H., Choe Y., Kim K., Son H., Motoi F., Egawa S., Unno M. Clock gene mouse period2 overexpression inhibits growth of human pancreatic cancer cells and has synergistic effect with cisplatin. Anticancer Res. 2009, 29:1201-1209.
15. Johnson C.H. Circadian clocks and cell division: what's the pacemaker?. Cell Cycle 2010, 9:3864-3873.
16. Miyazaki K., Wakabayashi M., Hara Y., Ishida N. Tumor growth suppression in vivo by overexpression of the circadian component, PER2. Genes Cells 2010, 15:351-358.
17. Yu E.A., Weaver D.R. Disrupting the circadian clock: gene-specific effects on aging, cancer, and other phenotypes. Aging 2011, 3:479-493.
18. Mazzoccoli G., Pazienza V., Panza A., Valvano M.R., Benegiamo G., Vinciguerra M., Andriulli A., Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J. Cancer Res. Clin. Oncol. 2012, 138:501-511.
19. Pendergast J.S., Yeom M., Reyes B.A., Ohmiya Y., Yamazaki S. Disconnected circadian and cell cycles in a tumor-driven cell line. Commun. Integr. Biol. 2010, 3:536-539.
20. Pietras A. Cancer stem cells in tumor heterogeneity. Adv. Cancer Res. 2011, 112:255-281.
21. Shibata M., Shen M.M. The roots of cancer: stem cells and the basis for tumor heterogeneity. BioEssays 2013, 35:253-260.
22. Balsalobre A., Damiola F., Schibler U. A serum shock induces circadian gene expression in mammalian tissue culture cells. Cell 1998, 93:929-937.
23. Akashi M., Nishida E. Involvement of the MAP kinase cascade in resetting of the mammalian circadian clock. Genes Dev. 2000, 14:645-649.
24. Welsh D.K., Yoo S.H., Liu A.C., Takahashi J.S., Kay S.A. Bioluminescence imaging of individual fibroblasts reveals persistent, independently phased circadian rhythms of clock gene expression. Curr. Biol. 2004, 14:2289-2295.
25. Patrawala L., Calhoun T., Schneider-Broussard R., Zhou J., Claypool K., Tang D.G. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res. 2005, 65:6207-6219.
26. An Y., Ongkeko W.M. ABCG2: the key to chemoresistance in cancer stem cells?. Expert Opin. Drug Metab. Toxicol. 2009, 5:1529-1542.
27. Mo W., Zhang J.T. Human ABCG2: structure, function, and its role in multidrug resistance. Int. J. Biochem. Mol. Biol. 2012, 3:1-27.
28. Scharenberg C.W., Harkey M.A., Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002, 99:507-512.
29. Wan F., Zhang S., Xie R., Gao B., Campos B., Herold-Mende C., Lei T. The utility and limitations of neurosphere assay, CD133 immunophenotyping and side population assay in glioma stem cell research. Brain Pathol. 2010, 20:877-889.
30. Lee J., Kotliarova S., Kotliarov Y., Li A., Su Q., Donin N.M., Pastorino S., Purow B.W., Christopher N., Zhang W., Park J.K., Fine H.A. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 2006, 9:391-403.
31. Li G., Chen Z., Hu Y.D., Wei H., Li D., Ji H., Wang D.L. Autocrine factors sustain glioblastoma stem cell self-renewal. Oncol. Rep. 2009, 21:419-424.
32. Kowalska E., Moriggi E., Bauer C., Dibner C., Brown S.A. The circadian clock starts ticking at a developmentally early stage. J. Biol. Rhythms 2010, 25:442-449.
33. Tsinkalovsky O., Filipski E., Rosenlund B., Sothern R.B., Eiken H.G., Wu M.W., Claustrat B., Bayer J., Levi F., Laerum O.D. Circadian expression of clock genes in purified hematopoietic stem cells is developmentally regulated in mouse bone marrow. Exp. Hematol. 2006, 34:1249-1261.
34. Yagita K., Horie K., Koinuma S., Nakamura W., Yamanaka I., Urasaki A., Shigeyoshi Y., Kawakami K., Shimada S., Takeda J., Uchiyama Y. Development of the circadian oscillator during differentiation of mouse embryonic stem cells in vitro. Proc. Natl. Acad. Sci. USA 2010, 107:3846-3851.
35. Mazzoccoli G., Francavilla M., Giuliani F., Aucella F., Vinciguerra M., Pazienza V., Piepoli A., Benegiamo G., Liu S., Cai Y. Clock gene expression in mouse kidney and testis: analysis of periodical and dynamical patterns. J. Biol. Regul. Homeost. Agents 2012, 26:303-311.
36. Alvarez J.D., Chen D., Storer E., Sehgal A. Non-cyclic and developmental stage-specific expression of circadian clock proteins during murine spermatogenesis. Biol. Reprod. 2003, 69:81-91.
37. Morse D., Cermakian N., Brancorsini S., Parvinen M., Sassone-Corsi P. No circadian rhythms in testis: Period1 expression is clock independent and developmentally regulated in the mouse. Mol. Endocrinol. 2003, 17:141-151.
38. Alvarez J.D., Sehgal A. The thymus is similar to the testis in its pattern of circadian clock gene expression. J. Biol. Rhythms 2005, 20:111-121.
39. Paulose J.K., Rucker E.B., Cassone V.M. Toward the beginning of time: circadian rhythms in metabolism precede rhythms in clock gene expression in mouse embryonic stem cells. PLoS One 2012, 7:e49555.
40. Benda P., Lightbody J., Sato G., Levine L., Sweet W. Differentiated rat glial cell strain in tissue culture. Science 1968, 161:370-371.
41. Volpe J.J., Fujimoto K., Marasa J.C., Agrawal H.C. Relation of C-6 glial cells in culture to myelin. Biochem. J. 1975, 152:701-703.
42. Fan K., Uzman B.G. Rat glioma cells (C6) cultured in serum-free defined medium. Exp. Cell Res. 1977, 106:397-401.
43. Kondo T., Setoguchi T., Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc. Natl. Acad. Sci. USA 2004, 101:781-786.
44. Shen G., Shen F., Shi Z., Liu W., Hu W., Zheng X., Wen L., Yang X. Identification of cancer stem-like cells in the C6 glioma cell line and the limitation of current identification methods. In vitro Cell. Dev. Biol. Anim. 2008, 44:280-289.
45. Zhou X.D., Wang X.Y., Qu F.J., Zhong Y.H., Lu X.D., Zhao P., Wang D.H., Huang Q.B., Zhang L., Li X.G. Detection of cancer stem cells from the C6 glioma cell line. J. Int. Med. Res. 2009, 37:503-510.
46. Yagita K., Tamanini F., Yasuda M., Hoeijmakers J.H.J., van der Horst G.T.J., Okamura H. Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein. EMBO J. 2002, 21:1301-1314.
47. Abe M., Herzog E.D., Yamazaki S., Straume M., Tei H., Sakaki Y., Menaker M., Block G.D. Circadian rhythms in isolated brain regions. J. Neurosci. 2002, 22:350-356.
48. Li Q., Wu L., Oelschlager D.K., Wan M., Stockard C.R., Grizzle W.E., Wang N., Chen H., Sun Y., Cao X. Smad4 inhibits tumor growth by inducing apoptosis in estrogen receptor-alpha-positive breast cancer cells. J. Biol. Chem. 2005, 280:27022-27028.
49. Zhang G., Gurtu V., Kain S.R., Yan G. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques 1997, 23:525-531.
50. Yagita K., Tamanini F., Yasuda M., Hoeijmakers J.H., van der Horst G.T., Okamura H. Nucleocytoplasmic shuttling and mCRY-dependent inhibition of ubiquitylation of the mPER2 clock protein. EMBO J. 2002, 21:1301-1314.
51. Balsalobre A., Marcacci L., Schibler U. Multiple signaling pathways elicit circadian gene expression in cultured Rat-1 fibroblasts. Curr. Biol. 2000, 10:1291-1294.
52. Wang P., Suo Z., Wang M., Hoifodt H.K., Fodstad O., Gaudernack G., Kvalheim G. In vitro and in vivo properties of CD133 expressing cells from human lung cancer cell lines. Exp. Hematol. Oncol. 2013, 2:16.
53. Naylor C.S., Jaworska E., Branson K., Embleton M.J., Chopra R. Side population/ABCG2-positive cells represent a heterogeneous group of haemopoietic cells: implications for the use of adult stem cells in transplantation and plasticity protocols. Bone Marrow Transplant. 2005, 35:353-360.
54. Liu L., Li W.Y., Chen Q., Zheng J.K., Yang L.Y. The biological characteristics of glioma stem cells in human glioma cell line SHG44. Mol. Med. Rep. 2012, 5:552-558.
55. Srivastava A.S., Kaushal S., Mishra R., Lane T.A., Carrier E. Dexamethasone facilitates erythropoiesis in murine embryonic stem cells differentiating into hematopoietic cells in vitro. Biochem. Biophys. Res. Commun. 2006, 346:508-516.
56. Lee H.Y., Chung H.Y., Kim K.H., Lee J.J., Kim K.W. Induction of differentiation in the cultured F9 teratocarcinoma stem cells by triterpene acids. J. Cancer Res. Clin. Oncol. 1994, 120:513-518.
57. Segovia J., Vergara P., Brenner M. Differentiation-dependent expression of transgenes in engineered astrocyte cell lines. Neurosci. Lett. 1998, 242:172-176.
58. He S., Zhu W., Zhou Y., Huang Y., Ou Y., Li Y., Yan G. Transcriptional and post-transcriptional down-regulation of cyclin D1 contributes to C6 glioma cell differentiation induced by forskolin. J. Cell. Biochem. 2011, 112:2241-2249.
59. Cohen J.R., Resnick D.Z., Niewiadomski P., Dong H., Liau L.M., Waschek J.A. Pituitary adenylyl cyclase activating polypeptide inhibits gli1 gene expression and proliferation in primary medulloblastoma derived tumorsphere cultures. BMC Cancer 2010, 10:676.
60. Doi M., Ishida A., Miyake A., Sato M., Komatsu R., Yamazaki F., Kimura I., Tsuchiya S., Kori H., Seo K., Yamaguchi Y., Matsuo M., Fustin J.M., Tanaka R., Santo Y., Yamada H., Takahashi Y., Araki M., Nakao K., Aizawa S., Kobayashi M., Obrietan K., Tsujimoto G., Okamura H. Circadian regulation of intracellular G-protein signalling mediates intercellular synchrony and rhythmicity in the suprachiasmatic nucleus. Nat. Commun. 2011, 2:327.
61. Li Z., Ruan L., Lin S., Gittes G.K. Clock controls timing of mouse pancreatic differentiation through regulation of Wnt- and Notch-based and cell division components. Biochem. Biophys. Res. Commun. 2007, 359:491-496.
62. Allen J.E., Hart L.S., Dicker D.T., Wang W., El-Deiry W.S. Visualization and enrichment of live putative cancer stem cell populations following p53 inactivation or Bax deletion using non-toxic fluorescent dyes. Cancer Biol. Ther. 2009, 8:2194-2205.
63. Geusz M.E., Blakely K.T., Hiler D.J., Jamasbi R.J. Elevated mPer1 gene expression in tumor stroma imaged through bioluminescence. Int. J. Cancer 2010, 126:620-630.
64. MacDonald H.R., Howell R.L., McFarlane D.L. The multicellular spheroid as a model tumor allograft. II. Characterization of spheroid-infiltrating cytotoxic cells. Transplantation 1978, 25:141-145.
65. Wittig R., Richter V., Wittig-Blaich S., Weber P., Strauss W.S., Bruns T., Dick T.P., Schneckenburger H. Biosensor-expressing spheroid cultures for imaging of drug-induced effects in three dimensions. J. Biomol. Screen. 2013, 18:736-743.
66. Almanaa T.N., Geusz M.E., Jamasbi R.J. A new method for identifying stem-like cells in esophageal cancer cell lines. J. Cancer 2013, 4:536-548.
67. Hong X., Chedid K., Kalkanis S.N. Glioblastoma cell line-derived spheres in serumcontaining medium versus serum-free medium: a comparison of cancer stem cell properties. Int. J. Oncol. 2012, 41:1693-1700.
68. Zhang S.J., Ye F., Xie R.F., Hu F., Wang B.F., Wan F., Guo D.S., Lei T. Comparative study on the stem cell phenotypes of C6 cells under different culture conditions. Chin. Med. J. 2011, 124:3118-3126.
69. Maltese W.A., Volpe J.J. Induction of an oligodendroglial enzyme in C-6 glioma cells maintained at high density or in serum-free medium. J. Cell. Physiol. 1979, 101:459-469.
70. Obrietan K., Impey S., Smith D., Athos J., Storm D.R. Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J. Biol. Chem. 1999, 274:17748-17756.
71. Ghosh P., Singh U.N. Intercellular communication in rapidly proliferating and differentiated C6 glioma cells in culture. Cell Biol. Int. 1997, 21:551-557.
72. Galeffi F., Turner D.A. Exploiting metabolic differences in glioma therapy. Curr. Drug Discov. Technol. 2012, 9:280-293.
73. Ryu C.H., Park K.Y., Kim S.M., Jeong C.H., Woo J.S., Hou Y., Jeun S.S. Valproic acid enhances anti-tumor effect of mesenchymal stem cell mediated HSV-TK gene therapy in intracranial glioma. Biochem. Biophys. Res. Commun. 2012, 421:585-590.
74. Vik-Mo E.O., Sandberg C., Joel M., Stangeland B., Watanabe Y., Mackay-Sim A., Moe M.C., Murrell W., Langmoen I.A. A comparative study of the structural organization of spheres derived from the adult human subventricular zone and glioblastoma biopsies. Exp. Cell Res. 2011, 317:1049-1059.
75. McCord A.M., Jamal M., Shankavaram U.T., Lang F.F., Camphausen K., Tofilon P.J. Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro. Mol. Cancer Res. 2009, 7:489-497.
76. Segovia J., Lawless G.M., Tillakaratne N.J., Brenner M., Tobin A.J. Cyclic AMP decreases the expression of a neuronal marker (GAD67) and increases the expression of an astroglial marker (GFAP) in C6 cells. J. Neurochem. 1994, 63:1218-1225.
77. Powell P.P., Klagsbrun M. Regulation of basic fibroblast growth factor mRNA expression in rat C6 glioma cells. Exp. Cell Res. 1993, 209:224-230.
78. Westermann R., Hardung M., Meyer D.K., Ehrhard P., Otten U., Unsicker K. Neuronotrophic factors released by C6 glioma cells. J. Neurochem. 1988, 50:1747-1758.
79. Westermann R., Mollenhauer J., Johannsen M., Unsicker K. Laminin and other basal lamina proteins with neurite promoting activity in medium conditioned by C6 glioma cells. Int. J. Dev. Neurosci. 1989, 7:219-230.
80. Hoelzinger D.B., Demuth T., Berens M.E. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment. J. Natl. Cancer Inst. 2007, 99:1583-1593.